Challenges in Patient Enrollment and Retention in Clinical Studies for Alcoholic Hepatitis: Experience of the TREAT Consortium-Reference-Cited by-同舟云学术

Challenges in Patient Enrollment and Retention in Clinical Studies for Alcoholic Hepatitis: Experience of the TREAT Consortium

Published:2017-10-27 Issue:12 Volume:41 Page:2000-2006
ISSN:0145-6008
Container-title:Alcoholism: Clinical and Experimental Research
language:en
Short-container-title:Alcohol Clin Exp Res

Author:

Comerford Megan¹,Lourens Spencer²,Liangpunsakul Suthat¹³^ORCID,Chalasani Naga P.¹,Sanyal Arun J.⁴,Shah Vijay H.⁵,Kamath Patrick S.⁵,Puri Puneet⁴,Katz Barry P.²,Radaeva Svetlana⁶,Crabb David W.¹⁷^ORCID

Affiliation:

1. Department of Medicine; Division of Gastroenterology and Hepatology; Indiana University School of Medicine; Indianapolis Indiana

2. Department of Biostatistics; Indiana University School of Medicine and Richard M. Fairbanks School of Public Health; Indianapolis Indiana

3. Roudebush Veterans Administration Medical Center; Indianapolis Indiana

4. Department of Medicine; Division of Gastroenterology and Hepatology; Virginia Commonwealth University; Richmond Virginia

5. Division of Gastroenterology and Hepatology; Mayo Clinic; Rochester Minnesota

6. National Institute on Alcohol Abuse and Alcoholism; National Institutes of Health; Rockville Maryland

7. Eskenazi Health; Indianapolis Indiana

Funder

National Institutes of Health

Evolving Alcoholic hepatitis Treatment (TREAT) Consortium

Publisher

Wiley

Subject

Psychiatry and Mental health,Toxicology,Medicine (miscellaneous)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/acer.13515/fullpdf

Reference12 articles.

1. Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study;Addolorato;Lancet,2007

2. A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis;Buch;Nat Genet,2015

3. PNPLA3 I148M (rs738409) genetic variant and age at onset of at-risk alcohol consumption are independent risk factors for alcoholic cirrhosis;Burza;Liver Int,2014

4. Systematic review with meta-analysis: the I148M variant of patatin-like phospholipase domain-containing 3 gene (PNPLA3) is significantly associated with alcoholic liver cirrhosis;Chamorro;Aliment Pharmacol Ther,2014

5. Trends in alcoholic hepatitis-related hospitalizations, financial burden, and mortality in the United States;Jinjuvadia;J Clin Gastroenterol,2015

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From O’Shaughnessy to opportunity: innovating Hepatology Trials in the UK;Frontline Gastroenterology;2024-07-13

2. Designing clinical trials to address alcohol use and alcohol-associated liver disease: an expert panel Consensus Statement;Nature Reviews Gastroenterology & Hepatology;2024-06-07

3. Inequity in clinical research access for service users presenting comorbidity within alcohol treatment settings: findings from a focused ethnographic study;International Journal for Equity in Health;2024-05-22

4. Randomized trial of anakinra plus zinc vs. prednisone for severe alcohol-associated hepatitis;Journal of Hepatology;2024-05

5. Development and evaluation of objective trial performance metrics for multisite clinical studies: Experience from the AlcHep Network;Contemporary Clinical Trials;2024-03